Form D — Avery Therapeutics, Inc.
0001708135-26-000003 · filed Sep 21, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $15,400,000
- Total sold
- $8,468,859
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Avery Therapeutics, Inc.
- CIK
- 1708135
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2500 N. TUCSON BLVD. STE. 140
TUCSON, AZ 85716 - Phone
- 520-977-4980
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jordan Lancaster · Executive OfficerTucson, AZ Find on LinkedIn ↗
-
Lawrence Mehren · DirectorTucson, AZ Find on LinkedIn ↗
-
Emile Nuwaysir · DirectorTucson, AZ Find on LinkedIn ↗
-
Steven Goldman · Executive OfficerTucson, AZ Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗